US 8133861
Systemic purine administration: modulating axonal outgrowth of central nervous system neurons
granted A61KA61K31/7076A61K31/708
Quick answer
US patent 8133861 (Systemic purine administration: modulating axonal outgrowth of central nervous system neurons) held by Alseres Pharmaceuticals, Inc. expires Mon Mar 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alseres Pharmaceuticals, Inc.
- Grant date
- Tue Mar 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K31/7076, A61K31/708, A61K45/06, A61K47/02